Cite

    Rafael Caparica et al.. “Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives.” Therapeutic advances in medical oncology, vol. 11, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100099956575.0x000012